SYMMETRYRX
DEAD

Serial Number

97456625

Owner

SymmetryRx LLC

Attorney

Frank J. Bonini, Jr.

Filing Date

Jun 14, 2022

Add to watchlist:

No watchlists yet
View on USPTO

SYMMETRYRX Trademark

Serial Number: 97456625

SYMMETRYRX is a trademark filed by SymmetryRx LLC on June 14, 2022. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

SymmetryRx LLC

Suite F200
RADNOR, PA 19087

Entity Type: 16

Trademark Details

Filing Date

June 14, 2022

Registration Date

Not Registered

Goods & Services

Platform as a service (PAAS) featuring computer software platforms for enabling sponsoring pharmaceutical manufacturers to communicate with prospective customer patients about prescription medications; Platform as a service (PAAS) featuring computer software platforms for administering and managing patient support services, namely, computer software platforms for providing patient information and resources for medications, conditions, or other healthcare issues; Platform as a service (PAAS) featuring computer software platforms for managing electronic prescription work flow and electronic healthcare records, namely, computer software platforms for requesting and fulfilling online orders for pharmaceutical samples, and for viewing, editing, and storing electronic healthcare records; Platform as a service (PAAS) featuring computer software platforms for operating a prescription eligibility program for patients and prescribers, namely, computer software platforms for qualifying patients for discounts for prescriptions; Platform as a service (PAAS) featuring computer software platforms for communicating offers for prescriptions to prospective customer patients; Platform as a service (PAAS) featuring computer software platforms for managing patient consents, namely, computer software platforms for obtaining and storing patient consents; Platform as a service (PAAS) featuring computer software platforms for recording patient consents; Platform as a service (PAAS) featuring computer software platforms for managing prescription routing for fulfillment and delivery of prescriptions to patients; Platform as a service (PAAS) featuring computer software platforms for providing patients with medication information, educational materials, and adherence support services sponsored by the manufacturer from the program pharmacy; Platform as a service (PAAS) featuring computer software platforms for analyzing and optimizing patient selection and prescription program management, namely, computer software platforms for matching patients with potential discount programs; Platform as a service (PAAS) featuring computer software platforms for providing data security in accordance with applicable regulations in the field of prescription medications

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Feb 17, 2026 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Feb 17, 2026 ABN2
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 15, 2025 GNFN
FINAL REFUSAL E-MAILED
Oct 15, 2025 GNFR
FINAL REFUSAL WRITTEN
Oct 15, 2025 CNFR
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jul 5, 2025 RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jan 3, 2025 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 22, 2024 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 28, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 28, 2023 GNSL
SUSPENSION LETTER WRITTEN
Jun 28, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 11, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 10, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 10, 2023 TROA
ASSIGNED TO EXAMINER
Dec 28, 2022 DOCK
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 9, 2022 GNRN
NON-FINAL ACTION E-MAILED
Oct 9, 2022 GNRT
NON-FINAL ACTION WRITTEN
Oct 9, 2022 CNRT
ASSIGNED TO EXAMINER
Oct 2, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 27, 2022 NWOS
NEW APPLICATION ENTERED
Jun 17, 2022 NWAP